Vyepti 100mg/1ml Vial Single Dose is administered by intravenous infusion, helps prevent migraine attacks and reduces the number of migraine days in adults who experience migraines at least 4 days per month.

Vyepti ingredients

Vyepti contains the active ingredient eptinezumab, which blocks the activity of calcitonin gene-related peptide (CGRP) — a molecule found at elevated levels in people with migraine.

Veypti uses

• Vyepti is used for the prevention of migraine in adults who experience migraine symptoms at least 4 days per month.

• It helps reduce the number of migraine days and improve quality of life. Its preventive effect begins the day after administration.

Dosage of Vyepti 100 mg/1 mL

Vyepti is administered by intravenous infusion over 30 minutes by a healthcare professional.

• The recommended dose is 100 mg every 12 weeks.

• Some patients may require a 300 mg dose every 12 weeks.

Vyepti side effects

Possible side effects include:

• Sore throat

• Nasal congestion

• Fatigue

Contraindications

Vyepti should not be used in:

• Patients with hypersensitivity to its ingredients

• Children and adolescents under 18 years of age

Warnings and Precautions

Use with caution and consult a doctor before using Vyepti, especially in cases of:

• Pregnancy and breastfeeding

• Cardiovascular diseases

Storage Instructions

• Keep out of the reach of children.

• Store in a refrigerator at 2–8°C.

• Do not freeze.

• If removed from the refrigerator, it may be kept at room temperature (25°C) in its original carton for up to 7 days; discard if not used afterward.
  After dilution, the solution may be stored at room temperature (25°C) or in a refrigerator (2–8°C) and must be used within 8 hours.

• Store in the original package, protected from light.